Correction: 4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis.
Publication Title
RMD Open
Document Type
Article
Publication Date
3-26-2018
Keywords
anti-tnf; dmards (biologic); psoriatic arthritis; tnf-alpha
Abstract
[This corrects the article DOI: 10.1136/rmdopen-2017-000582.][This corrects the article DOI: 10.1136/rmdopen-2017-000582.].
Clinical Institute
Orthopedics & Sports Medicine
Specialty/Research Institute
Orthopedics
Specialty/Research Institute
Rheumatology
COinS
